Eléments de l'association
| ![]() |
List of bibliographic references
Number of relevant bibliographic references: 3.Ident. | Authors (with country if any) | Title |
---|---|---|
000A80 | Allison Martin [Australie] ; Cecilia Moore [Australie] ; Patrick W. G. Mallon [Irlande (pays)] ; Jennifer Hoy [Australie] ; Sean Emery [Australie] ; Waldo Belloso [Argentine] ; Praphan Phanuphak [Thaïlande] ; Samuel Ferret [France] ; David A. Cooper [Australie] ; Mark A. Boyd [Australie] | Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy |
002474 | Rebekah L. Puls [Australie] ; Preeyaporn Srasuebkul [Australie] ; Kathy Petoumenos [Australie] ; Christoph Boesecke [Australie] ; Chris Duncombe [Thaïlande] ; Waldo H. Belloso [Argentine] ; Jean-Michel Molina [France] ; LIN LI [Singapour] ; Anchalee Avihingsanon [Thaïlande] ; Brian Gazzard [Royaume-Uni] ; David A. Cooper [Australie] ; Sean Emery [Australie] | Efavirenz versus Boosted Atazanavir or Zidovudine and Abacavir in Antiretroviral Treatment-Naive, HIV-Infected Subjects: Week 48 Data from the Altair Study |
004098 | Charles B. Hicks [États-Unis] ; Pedro Cahn [Argentine] ; David A. Cooper [Australie] ; Sharon L. Walmsley [Canada] ; Christine Katlama [France] ; Bonaventura Clotet [Espagne] ; Adriano Lazzarin [Italie] ; Margaret A. Johnson [Royaume-Uni] ; Dietmar Neubacher [Allemagne] ; Douglas Mayers [États-Unis] ; Hernan Valdez [États-Unis] | Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the randomized evaluation of strategic intervention in multi-drug resistant patients with tipranavir (RESIST) studies : an analysis of combined data from two randomised open-label trials |
![]() | This area was generated with Dilib version V0.6.33. | ![]() |